Aortic Stenosis: New Insights in Diagnosis, Treatment, and Prevention

Saki Ito1, Jae K Oh2

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Insights

Aortic stenosis (AS) is a growing concern in the elderly population. Early detection and new treatments like transcatheter aortic valve replacement (TAVR) are crucial for managing this complex heart disease.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Valvular Heart Disease

Background:

  • Aortic stenosis (AS) is a prevalent valvular heart disease, with increasing global incidence due to aging populations.
  • AS in the elderly often presents with complex comorbidities beyond left ventricular outflow obstruction.
  • Identifying high-risk patients and enabling earlier AS detection is critical for timely intervention.

Purpose of the Study:

  • To review recent advancements in understanding and managing aortic stenosis.
  • To discuss the evolving role of transcatheter aortic valve replacement (TAVR) in AS management.
  • To explore emerging medical therapies for preventing or slowing AS progression.

Main Methods:

  • Comprehensive literature review of recent findings in aortic stenosis.
  • Analysis of current evidence regarding transcatheter aortic valve replacement (TAVR) efficacy and safety.
  • Examination of ongoing randomized controlled trials for novel medical therapies.

Main Results:

  • Transcatheter aortic valve replacement (TAVR) has demonstrated efficacy and safety in severe AS.
  • Growing interest exists in applying TAVR to patients with less than severe AS.
  • Medical therapies to mitigate AS progression are under active investigation.

Conclusions:

  • Effective management of aortic stenosis requires addressing its complexity and comorbidities in the elderly.
  • Earlier detection and risk stratification are paramount for optimizing patient outcomes.
  • Future strategies will likely involve a combination of TAVR and novel medical therapies to manage AS progression.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
34
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
25
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
19
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
23
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
17